A Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Selected Surgeries
NCT ID: NCT06887959
Last Updated: 2025-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
47 participants
INTERVENTIONAL
2025-03-27
2025-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Auricular Vagus Nerve Stimulation (aVNS) in Chronic Spinal Cord Injuries (SCI)
NCT06588608
Effects of taVNS on Postoperative Pain in Complex Spinal Surgery
NCT07330973
Pulsed Short Wave Therapy In Cesarean Section
NCT03604068
Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Gastrectomy
NCT02522598
Effects of Vagus Nerve Stimulation on Temporomandibular Disorders.
NCT07288411
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Suzetrigine (SUZ)
Participants will receive SUZ for 14 days or until their pain resolves, whichever occurs first.
Suzetrigine
Tablets for oral administration.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Suzetrigine
Tablets for oral administration.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled to undergo a procedure that is in one of the following categories that would typically be treated with opioid therapy for at least 72 hours postoperatively such as
* Laparoscopic intraperitoneal or retroperitoneal procedure
* Arthroscopic orthopedic procedure
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vertex Pharmaceuticals Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Scottsdale Clinical Trials
Scottsdale, Arizona, United States
Woodland International Research Group
Little Rock, Arkansas, United States
Gulfcoast Research Institute
Sarasota, Florida, United States
MedStar
Baltimore, Maryland, United States
Oasis Clinical Research
Las Vegas, Nevada, United States
Cooper University HealthCare (CUH)
Camden, New Jersey, United States
North Shore University Hospital - Anesthesiology
Manhasset, New York, United States
OrthoCarolina - Hip & Knee Center
Charlotte, North Carolina, United States
Eximia Research-Durham
Durham, North Carolina, United States
Duke University Hospital - Anesthesiology
Durham, North Carolina, United States
West Clinical Research
Morehead City, North Carolina, United States
Seaside Clinical Research Institute
Wilmington, North Carolina, United States
UH Cleveland Medical Center - Anesthesiology
Cleveland, Ohio, United States
University of Tennessee Medical Center - Anethesiology
Knoxville, Tennessee, United States
HD Research LLC | First Surgical Hospital
Bellaire, Texas, United States
Memorial Hermann Village
Houston, Texas, United States
Tidewater Clinical Research
Norfolk, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VX24-548-108
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.